Literature DB >> 11052577

Nomenclature for COX-2 inhibitors.

J R Vane1, T D Warner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11052577     DOI： 10.1016/s0140-6736(00)02837-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Treating acute gouty arthritis with selective COX 2 inhibitors.

Authors:  Adel G Fam
Journal:  BMJ       Date:  2002-11-02

Review 2.  The second generation of COX-2 inhibitors: what advantages do the newest offer?

Authors:  Dirk O Stichtenoth; Jürgen C Frölich
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.

Authors:  P A Gray; T D Warner; I Vojnovic; P Del Soldato; A Parikh; G K Scadding; J A Mitchell
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

4.  A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee.

Authors:  M Bianchi; M Broggini
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenase.

Authors:  Mia Sandberg; Umit Yasar; Patrik Strömberg; Jan-Olov Höög; Erik Eliasson
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.